User:Mr. Ibrahem/Abrocitinib

Abrocitinib, sold under the brand name Cibinqo, is a medication used to treat atopic dermatitis (eczema). It may be used in cases that do not improve with other treatments. It is taken by mouth.

Common side effects include nausea, headache, herpes simplex, urinary tract infection, acne, impetigo, and low platelets. Other side effects may include infections, sudden cardiac death, pulmonary embolism, and cancer. Safety in pregnancy is unclear. It is a Janus kinase inhibitor.

Abrocitinib was approved for medical use in Europe in 2021 and the United States in 2022. In the United Kingdom 4 weeks of treatments cost the NHS about £900 as of 2021. In the United States this amount costs about 4,600 USD as of 2022.